Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial
Miras, Alexander Dimitri, Pérez-Pevida, Belén, Aldhwayan, Madhawi, Kamocka, Anna, McGlone, Emma Rose, Al-Najim, Werd, Chahal, Harvinder, Batterham, Rachel L, McGowan, Barbara, Khan, Omar, Greener, VerJournal:
The Lancet Diabetes & Endocrinology
DOI:
10.1016/S2213-8587(19)30157-3
Date:
June, 2019
File:
PDF, 455 KB
2019